A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Trial Profile

A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Anorgasmia
  • Focus Therapeutic Use
  • Acronyms AMB
  • Sponsors Acerus Pharmaceuticals; Trimel Pharmaceuticals Corporation
  • Most Recent Events

    • 16 Oct 2017 Trimel Pharmaceuticals Corporation changed it's name to Acerus Pharmaceuticals Corporation on 9 September 2015.
    • 16 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jul 2014 Top-line results published in a Trimel Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top